|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2000-5-1
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Eleven clonally related Klebsiella pneumoniae isolates were examined. These had been isolated at an intensive care unit in Amsterdam in 1994. Their resistance was associated with a conjugative 170-kb plasmid which encoded a novel SHV beta-lactamase designated SHV-13. The SHV-13 enzyme had two substitutions compared with SHV-1: Leu35Gln and Gly238Ala. It hydrolyzed cefotaxime much more rapidly than ceftazidime or aztreonam.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/10722518-1952834,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10722518-2039479,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10722518-2221867,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10722518-7009583,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10722518-7486909,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10722518-7501463,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10722518-7574506,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10722518-8429044,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10722518-8864938,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10722518-8889716,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10722518-9145849,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10722518-9574728,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10722518-9630406,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10722518-9705386,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10722518-9738084,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10722518-9767057
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0066-4804
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1081-4
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:10722518-Anti-Bacterial Agents,
pubmed-meshheading:10722518-Cross Infection,
pubmed-meshheading:10722518-DNA Fingerprinting,
pubmed-meshheading:10722518-Intensive Care Units, Neonatal,
pubmed-meshheading:10722518-Kinetics,
pubmed-meshheading:10722518-Klebsiella Infections,
pubmed-meshheading:10722518-Klebsiella pneumoniae,
pubmed-meshheading:10722518-Microbial Sensitivity Tests,
pubmed-meshheading:10722518-Molecular Sequence Data,
pubmed-meshheading:10722518-Netherlands,
pubmed-meshheading:10722518-Plasmids,
pubmed-meshheading:10722518-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:10722518-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:10722518-beta-Lactamases,
pubmed-meshheading:10722518-beta-Lactams
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
SHV-13, a novel extended-spectrum beta-lactamase, in Klebsiella pneumoniae isolates from patients in an intensive care unit in Amsterdam.
|
|
pubmed:affiliation |
Department of Medical Microbiology, St. Bartholomew's and The Royal London School of Medicine and Dentistry, London E1 2AD, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
